Can bupropion (Wellbutrin) cause or worsen restless leg syndrome, and how should it be managed?

Bupropion and Restless Leg Syndrome

Bupropion (Wellbutrin) does not cause or worsen restless leg syndrome (RLS) and may actually improve RLS symptoms, making it a safe antidepressant choice for patients with RLS.

Key Guideline Recommendation

The 2025 American Academy of Sleep Medicine (AASM) clinical practice guideline explicitly states that bupropion should not be used as a primary treatment for RLS (conditional recommendation, moderate certainty of evidence) 1111111111. However, this recommendation addresses bupropion's efficacy for treating RLS, not whether it causes or worsens the condition.

Does Bupropion Cause RLS?

No. The FDA drug label for Wellbutrin lists "restlessness" as a postmarketing adverse reaction in the nervous system category 22, but this is distinct from RLS. Importantly, restlessness is a general symptom that can occur with dopaminergic medications and should not be confused with the specific diagnostic criteria for RLS.

Does Bupropion Improve RLS?

Yes, in the short term. Research evidence demonstrates:

• A randomized controlled trial showed bupropion 150 mg daily significantly improved RLS symptoms at 3 weeks (10.8-point reduction vs 6.0-point reduction with placebo, p=0.016), though this difference was not statistically significant at 6 weeks 3
• A systematic review concluded that bupropion may reduce RLS symptoms, at least in the short term 4
• Multiple case reports document successful resolution of antidepressant-induced RLS when switching to bupropion 567

Clinical Management Algorithm

When a patient needs an antidepressant and has RLS:

1. First choice: Bupropion - It will not worsen RLS and may provide symptomatic benefit 348

   • Start with 150 mg sustained-release daily
   • Can titrate to 300 mg if needed for depression

2. Avoid these antidepressants that worsen RLS:

   • Mirtazapine - associated with higher rates of RLS and periodic limb movements 4
   • Venlafaxine - may increase RLS symptoms 4
   • SSRIs (particularly citalopram) - can induce or worsen RLS through dopaminergic dysfunction 69

3. Alternative safe options if bupropion fails:

   • Trazodone - does not aggravate periodic limb movements 49
   • Sertraline - appears to be the SSRI with least RLS risk due to dopamine reuptake blocking 6

When a patient on bupropion develops RLS symptoms:

1. Do not discontinue bupropion - it is not the cause

2. Investigate other causes:

   • Check iron studies (ferritin <75 ng/mL, transferrin saturation <20%)
   • Review other medications (antipsychotics, antihistamines, SSRIs)
   • Assess for mimicking conditions (neuropathy, akathisia)

3. Treat RLS per AASM guidelines:

   • First-line: Iron supplementation if deficient (ferrous sulfate or IV iron) 11
   • Second-line: Gabapentin/pregabalin or opioids
   • Avoid dopamine agonists as standard therapy due to augmentation risk

Mechanism of Benefit

Bupropion's unique pharmacology explains its favorable profile in RLS:

• Inhibits dopamine and norepinephrine reuptake without serotonergic activity 2
• Increases dopamine neurotransmission in nucleus accumbens and prefrontal cortex 5
• This corrects dopaminergic hypoactivity implicated in RLS pathophysiology 68

Important Caveats

• The evidence for bupropion treating RLS is limited to short-term studies (3-6 weeks) 3
• Larger trials with dose titration are needed to establish bupropion as primary RLS therapy 3
• The AASM guideline's recommendation against bupropion for RLS treatment reflects insufficient evidence for this indication, not safety concerns 11
• Bupropion remains an excellent choice when antidepressant therapy is needed in patients with comorbid RLS 48

Drug Interaction Consideration

When using bupropion with levodopa or amantadine (dopamine agonists sometimes used for RLS), monitor for CNS toxicity including restlessness, agitation, tremor, and ataxia due to cumulative dopamine agonist effects 2. However, this is distinct from RLS itself.